logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onCalendarPlatformsJob offers
 

News

boto imprimir
Date: 06/06/2012

IDIBELL project, funded by EMBO

Dr. Antonio Gentilella has get an EMBO Long-Term Fellowship

The project, leaded by Dr. Antonio Gentilella and funded by an EMBO Long-Term Fellowship, is focussed on understanding the mechanisms by which the tumor suppressor p53, also known as the guardian of genome, is activated in response to ribosomal impairment, a cause of two rare anemias, DBA and 5-syndrome, both of which have the propensity to develop into cancer in later life.


Dr. Gentilella has recently joined George Thomas’s group at the IDIBELL from the University of Pennsylvania, Philadelphia, PA.




foto Dr. Antonio Gentilella has get an EMBO Long-Term Fellowship
Dr. Antonio Gentilella has get an EMBO Long-Term Fellowship

Share/Bookmark
 
© 2013 Institut d'Investigació Biomèdica de Bellvitge


Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications
New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications
New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




You have not yet answered the internal personal satisfaction survey. It will not take you more than five minutes. Your opinion is very important to improve IDIBELL.

Do you want to complete the survey now?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No